Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
about
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeModeling how CD46 deficiency predisposes to atypical hemolytic uremic syndromeEculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.Hemolytic uremic syndrome. Results of treatment with hemodialysis.Diagnosis and management of atypical hemolytic uremic syndrome in children: single centre experience.A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.Oliguric thrombotic microangiopathy during the fifth month of pregnancy.
P2860
Q24685473-C5EFE00D-8379-47B7-9E9C-F16AB3154746Q33372897-B72368A4-3213-491B-8B9E-7D72484F94FAQ33393107-1DB41F86-8950-4377-900D-F105C441FDE6Q33412143-F84420EB-4939-43AF-862A-EC710EE9F238Q33421822-26E6E2E5-9DFB-4D32-B6F0-C1BC0DEF36EAQ33461165-39156107-5D4D-4A29-A258-5FDF97EB6E00Q41892604-73245515-CBF0-4CD5-8C62-0AB789B42A75Q43175189-D01B72E1-19FD-4675-B543-5469D7D7452DQ54964265-3DED012C-7902-4F09-9A02-81EEA1754E5B
P2860
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
description
1974 nî lūn-bûn
@nan
1974 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
name
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
@ast
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
@en
type
label
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
@ast
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
@en
prefLabel
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
@ast
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
@en
P2093
P1433
P1476
Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation.
@en
P2093
O Kourilsky
W Stühlinger
P304
P356
10.1016/S0140-6736(74)90991-X
P407
P577
1974-09-01T00:00:00Z